33 datasets found
  1. d

    Minimum Data Set Frequency

    • catalog.data.gov
    • healthdata.gov
    • +1more
    Updated Feb 3, 2025
    + more versions
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Centers for Medicare & Medicaid Services (2025). Minimum Data Set Frequency [Dataset]. https://catalog.data.gov/dataset/minimum-data-set-frequency
    Explore at:
    Dataset updated
    Feb 3, 2025
    Dataset provided by
    Centers for Medicare & Medicaid Services
    Description

    The Minimum Data Set (MDS) Frequency data summarizes health status indicators for active residents currently in nursing homes. The MDS is part of the Federally-mandated process for clinical assessment of all residents in Medicare and Medicaid certified nursing homes. This process provides a comprehensive assessment of each resident's functional capabilities and helps nursing home staff identify health problems. Care Area Assessments (CAAs) are part of this process, and provide the foundation upon which a resident's individual care plan is formulated. MDS assessments are completed for all residents in certified nursing homes, regardless of source of payment for the individual resident. MDS assessments are required for residents on admission to the nursing facility, periodically, and on discharge. All assessments are completed within specific guidelines and time frames. In most cases, participants in the assessment process are licensed health care professionals employed by the nursing home. MDS information is transmitted electronically by nursing homes to the national MDS database at CMS. When reviewing the MDS 3.0 Frequency files, some common software programs e.g., ‘Microsoft Excel’ might inaccurately strip leading zeros from designated code values (i.e., "01" becomes "1") or misinterpret code ranges as dates (i.e., O0600 ranges such as 02-04 are misread as 04-Feb). As each piece of software is unique, if you encounter an issue when reading the CSV file of Frequency data, please open the file in a plain text editor such as ‘Notepad’ or ‘TextPad’ to review the underlying data, before reaching out to CMS for assistance.

  2. Center for Medicare and Medicaid Services (CMS) Nursing Home Match (MDS)

    • catalog.data.gov
    • cloud.csiss.gmu.edu
    • +1more
    Updated Jan 24, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Social Security Administration (2025). Center for Medicare and Medicaid Services (CMS) Nursing Home Match (MDS) [Dataset]. https://catalog.data.gov/dataset/center-for-medicare-and-medicaid-services-cms-nursing-home-match-mds
    Explore at:
    Dataset updated
    Jan 24, 2025
    Dataset provided by
    Social Security Administrationhttp://www.ssa.gov/
    Description

    The purpose of the project is to detect unreported Supplemental Security Income (SSI) recipient admissions to Title XIX institutions. A file containing SSN's of SSI recipients (all eligible individuals and members of eligible couples in current pay) will be matched against the Health Care Financing Administration's (HCFA) Minimum Data Set (MDS) database which contains admission, discharge, re-entry and assessment information about persons in Title XIX facilities for all 50 States and Washington, D.C. This database is updated monthly. The match will produce an output file containing MDS data pertinent to SSI eligibility on matched records. This data will be compared back to the SSR data to generate alerts to the Field Offices for their actions.

  3. Nursing Home Compare MDS Quality Measures

    • johnsnowlabs.com
    csv
    Updated Jan 20, 2021
    + more versions
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    John Snow Labs (2021). Nursing Home Compare MDS Quality Measures [Dataset]. https://www.johnsnowlabs.com/marketplace/nursing-home-compare-mds-quality-measures/
    Explore at:
    csvAvailable download formats
    Dataset updated
    Jan 20, 2021
    Dataset authored and provided by
    John Snow Labs
    Area covered
    United States
    Description

    This dataset contains quality measures displayed on Nursing Home Compare, based on the resident assessments that make up the nursing home Minimum Data Set (MDS). Each row contains a specific measure for a nursing home and includes the four-quarter score average and scores for individual quarter.

  4. Patient Assessment File (PAF)

    • catalog.data.gov
    • datahub.va.gov
    • +2more
    Updated Apr 25, 2021
    + more versions
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Department of Veterans Affairs (2021). Patient Assessment File (PAF) [Dataset]. https://catalog.data.gov/dataset/patient-assessment-file-paf
    Explore at:
    Dataset updated
    Apr 25, 2021
    Dataset provided by
    United States Department of Veterans Affairshttp://va.gov/
    Description

    The Patient Assessment File (PAF) database compiles the results of the Patient Assessment Instrument (PAI) questionnaire filled out for intermediate care Veterans Health Administration (VHA) patients. The PAI is filled out within two weeks of admission. It is also completed semi-annually on April 1st and October 1st for each patient by a registered nurse familiar with the patient. The PAI questions cover medical treatments, conditions, selected diagnoses, activities of daily living, behaviors, some rehabilitation therapies, and chronic respiratory support. The database is managed by the Geriatrics & Extended Care Strategic Health Care Group in the Office of Patient Care Services. It is currently running at the Austin Information Technology Center (AITC) and is stored in flat files. PAF's primary customer is the Allocation Resource Center (ARC) in Braintree MA. The ARC receives the data from AITC and combines it with data from the Patient Treatment File (PTF) which contains more detailed demographic and treatment information. The ARC builds ORACLE tables, assigning RUG II (Resource Utilization Group II) scores and weighted work units reflecting the level and type of care needed. The 16 different weighted work units, ranging from 479 to 1800, are a factor in the resource allocation and budget decisions on long-term care, and are used to measure efficiency. The data is also used in other reports to Central Office, the Veterans Integrated Service Networks, and the facilities. Several other units also use PAF information including the Decision Support System (DSS). Currently, PAF is in the process of being replaced by the Resident Assessment Instrument/Minimum Data Set (RAI/MDS). RAI/MDS uses a much more extensive questionnaire as its source of information. The RAI/MDS provides clinical data and care protocols in addition to the newer RUG III scores, and is required by the Centers for Medicare and Medicaid Service funded hospitals.

  5. Facility-Level Minimum Data Set Frequency

    • catalog.data.gov
    • healthdata.gov
    • +1more
    Updated Feb 3, 2025
    + more versions
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Centers for Medicare & Medicaid Services (2025). Facility-Level Minimum Data Set Frequency [Dataset]. https://catalog.data.gov/dataset/facility-level-minimum-data-set-frequency
    Explore at:
    Dataset updated
    Feb 3, 2025
    Dataset provided by
    Centers for Medicare & Medicaid Services
    Description

    The Facility-Level Minimum Data Set (MDS) Frequency dataset provides information for active nursing home residents on topics, such as race/ethnicity, age, or marital status; discharge dispositions; hearing, speech, and vision; cognitive patterns; mood; functional abilities and goals; bladder and bowel; active diagnoses; health conditions; swallowing/nutritional status; oral/dental status; skin conditions; medications; special treatments, procedures, and programs; restraints and alarms; and participation in assessment and goal setting. Note: The MDS dataset contains more records than most spreadsheet programs can handle. The use of a database or statistical software is generally required. The dataset can be filtered to a more manageable size for use in a spreadsheet program by clicking on the “View Data” button. Additional filter information can be found in the methodology, if needed.

  6. F-tests of the marginal effects of unique MDS dimensions and self-reported...

    • plos.figshare.com
    xls
    Updated May 31, 2023
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Daniel E. Adkins; Renan P. Souza; Karolina Åberg; Shaunna L. Clark; Joseph L. McClay; Patrick F. Sullivan; Edwin J. C. G. van den Oord (2023). F-tests of the marginal effects of unique MDS dimensions and self-reported ethnicity. [Dataset]. http://doi.org/10.1371/journal.pone.0055239.t004
    Explore at:
    xlsAvailable download formats
    Dataset updated
    May 31, 2023
    Dataset provided by
    PLOShttp://plos.org/
    Authors
    Daniel E. Adkins; Renan P. Souza; Karolina Åberg; Shaunna L. Clark; Joseph L. McClay; Patrick F. Sullivan; Edwin J. C. G. van den Oord
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Description

    MDS – multidimensional scaling.For both samples, in more models than expected by chance the marginal effect of the MDS dimensions significantly improved model fit, over and above self-reported ethnicity. Self-reported ethnicity showed mixed statistical evidence of improving model fit conditional on the MDS dimensions.

  7. S

    Data generated for "Serial MRD assessment predicts relapse after...

    • snd.se
    csv, xlsx
    Updated Aug 23, 2024
    + more versions
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Magnus Tobiasson (2024). Data generated for "Serial MRD assessment predicts relapse after transplantation in patients with myelodysplastic syndrome. [Dataset]. http://doi.org/10.48723/hk61-4f76
    Explore at:
    csv(1504), xlsx(9815), xlsx(11300)Available download formats
    Dataset updated
    Aug 23, 2024
    Dataset provided by
    Karolinska Institutet
    Swedish National Data Service
    Authors
    Magnus Tobiasson
    License

    https://snd.se/en/search-and-order-data/using-datahttps://snd.se/en/search-and-order-data/using-data

    Time period covered
    2016 - 2021
    Description

    The study has evaluated the association between measurable residual disease (MRD) determined using digital droplet PCR (ddPCR) and outcome after allogeneic stem cell transplantation for patients with myelodysplastic syndrome (MDS). The patient-specific mutations have been identified using next generation sequencing (NGS).

    The dataset contains: 1. NGS data 2. MRD data 3. List of ddPCR-assays 4. Variants for ddPCR only identified at diagnosis 5. Variants of undetermined significance targeted by ddPCR 6. Regression analyses

  8. f

    Descriptive statistics and gender differences for all variables included in...

    • plos.figshare.com
    xls
    Updated Jun 5, 2023
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Abigail Millings; Shannon L. Hirst; Fuschia Sirois; Catherine Houlston (2023). Descriptive statistics and gender differences for all variables included in cluster and MDS analyses for Sample 2. [Dataset]. http://doi.org/10.1371/journal.pone.0239712.t007
    Explore at:
    xlsAvailable download formats
    Dataset updated
    Jun 5, 2023
    Dataset provided by
    PLOS ONE
    Authors
    Abigail Millings; Shannon L. Hirst; Fuschia Sirois; Catherine Houlston
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Description

    Descriptive statistics and gender differences for all variables included in cluster and MDS analyses for Sample 2.

  9. E

    The Voice Conversion Challenge, 2016: multidimensional scaling (MDS)...

    • dtechtive.com
    • find.data.gov.scot
    pdf, txt, zip
    Updated Oct 14, 2016
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    University of Edinburgh. School of Informatics. Centre for Speech Technology Research (2016). The Voice Conversion Challenge, 2016: multidimensional scaling (MDS) listening test results [Dataset]. http://doi.org/10.7488/ds/1504
    Explore at:
    zip(0.2615 MB), txt(0.0026 MB), pdf(0.1498 MB), txt(0.0166 MB)Available download formats
    Dataset updated
    Oct 14, 2016
    Dataset provided by
    University of Edinburgh. School of Informatics. Centre for Speech Technology Research
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Area covered
    UNITED KINGDOM
    Description

    The Voice Conversion Challenge (VCC) 2016, one of the special sessions at Interspeech 2016, deals with speaker identity conversion, referred as Voice Conversion (VC). The task of the challenge was speaker conversion, i.e., to transform the voice identity of a source speaker into that of a target speaker while preserving the linguistic content. Using a common dataset consisting of 162 utterances for training and 54 utterances for evaluation from each of 5 source and 5 target speakers, 17 groups working in VC around the world developed their own VC systems for every combination of the source and target speakers, i.e., 25 systems in total, and generated voice samples converted by the developed systems. The objective of the VCC was to compare various VC techniques on identical training and evaluation speech data. The samples were evaluated in terms of target speaker similarity and naturalness by 200 listeners in a controlled environment. This section of the VCC repository contains the listening test results for four of the source-target pairs (two intra-gender and two cross-gender) in more detail. Multidimensional scaling was performed to illustrate where each system was perceived to be in an acoustic space compared to the source and target speakers and to each other. See also item 'The Voice Conversion Challenge 2016' (DOI: 10.7488/ds/1430)

  10. Data from: Recommendations of older adults on how to use the PROM...

    • figshare.com
    bin
    Updated Oct 29, 2019
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Ruth Pel-Littel (2019). Recommendations of older adults on how to use the PROM ‘TOPICS-MDS’ in healthcare conversations: a Delphi study [Dataset]. http://doi.org/10.6084/m9.figshare.10001906.v1
    Explore at:
    binAvailable download formats
    Dataset updated
    Oct 29, 2019
    Dataset provided by
    figshare
    Authors
    Ruth Pel-Littel
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Description

    SPSS Dataset with the ranking data of the health domains of the TOPICS-MDS as assessed by the participants of the first round of the Delphi study.

  11. m

    Comparison of ten sequential online motor assessment of patients with...

    • data.mendeley.com
    Updated Feb 9, 2024
    + more versions
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Samah Mostafa (2024). Comparison of ten sequential online motor assessment of patients with Parkinson disease by multiple raters in different locations [Dataset]. http://doi.org/10.17632/2wf998hxfv.1
    Explore at:
    Dataset updated
    Feb 9, 2024
    Authors
    Samah Mostafa
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Description

    Detection of movements in the extremities of people with Parkinson disease was developed to enhance clinical assessments. This data represents the administration of online motor assessments to detect the movements in the extremities of people with Parkinson's disease by examiners certified in the Movement Disorders Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) (Goetz, et al., 2008).

    Ten trained raters who were certified in the administration of the Movement Disorders Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) (Goetz, et al., 2008) conducted 10 online motor assessments for one patient with Parkinson disease. Each rater utilized a separate computer at different location in three continents. At the beginning of each session the patient was asked for his permission to record the session. Second, the investigator asked the patient about the current medications and weight. Third, the investigator announced each motor assessment by saying the number and the name of each task before conducting the task for all of the raters. Fourth, the investigator gave the patient the specific instructions for each task, demonstrated each task, and asked the participant to begin the task. The investigator didn't continue to demonstrate the task after the participant began the task. For the repetitive items the investigator asked the participant to perform the activities as fully and as fast as possible. After performing each task the raters were given one minute to write their scores. This process was repeated for all of the tasks. At the conclusion of the session the participant was excused after setting the next session date, and then all of the raters shared their scores with the investigator by email. Finally the investigator conducted a consensus conference to attain agreement on each score for each task.

    One expert certified in the MDS-UPDRS (Goetz, et al., 2008) edited the original videotapes to extract only the administration of each task.The videotape segments correspond to the tasks of the protocol (3.17RTU: 3.17 Rest tremor amplitude upper limbs, 3.17RTUC: 3.17 Rest tremor amplitude upper limbs counting, 3.15PT: 3.15 Postural tremor of the hands, 3.4FT: 3.4 Finger tapping, 3.5HM: 3.5 Hand movements, 3.6PS: 3.6 Pronation-supination movements of the hands, 3.9ACU: 3.9 Arising from chair upper limbs).

  12. Comparison between MC-MDS and metric MDS.

    • plos.figshare.com
    xls
    Updated Jun 2, 2023
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Zhipeng Cai; Tong Zhang; Xiu-Feng Wan (2023). Comparison between MC-MDS and metric MDS. [Dataset]. http://doi.org/10.1371/journal.pcbi.1000949.t002
    Explore at:
    xlsAvailable download formats
    Dataset updated
    Jun 2, 2023
    Dataset provided by
    PLOShttp://plos.org/
    Authors
    Zhipeng Cai; Tong Zhang; Xiu-Feng Wan
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Description

    1HI recovery ability is assessed by calculating the RMSE values on the Type I data using -fold cross validation, and these values are also called local RMSEs.2A correlation coefficient (CC value) is calculated from the pairwise distances among antigens for every two independent runs. The CC values in this table were calculated from different runs.3A maximum distance (MD value) refers to the difference between the maximum distance among any antigens in the benchmark cartography and that from the method being evaluated (either MC-MDS or metric MDS). The MD values in this table were calculated from different runs.4A pairwise distance RMSE (PD value) is the difference between the pairwise distances among all antigens in the benchmark cartography and those from the method being evaluated. The PD values in this table were calculated from different runs. The PD values for H3N2 data were not assessed since we do not know the ground truth of antigenic cartography for this dataset.5The value in the bracket is the standard deviation of the associated parameter.

  13. T

    Veterans Equitable Resource Allocation (VERA)

    • data.va.gov
    • datahub.va.gov
    • +3more
    application/rdfxml +5
    Updated Sep 12, 2019
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    (2019). Veterans Equitable Resource Allocation (VERA) [Dataset]. https://www.data.va.gov/widgets/tq29-drkf
    Explore at:
    csv, xml, json, tsv, application/rssxml, application/rdfxmlAvailable download formats
    Dataset updated
    Sep 12, 2019
    Description

    The Veterans Equitable Resource Allocation (VERA) database, is operated by the Allocation Resource Center (ARC) in Braintree, MA. The ARC is part of the Resource Allocation & Execution Office of the Office of Finance. The database is developed from the Patient Treatment File, National Patient Care Database, Fee Basis Medical and Pharmacy System, Decision Support System (DSS) National extracts, DSS Derived Monthly Program Cost Report (MPCR), Resident Assessment Instrument (RAI) Minimum Data Set (MDS), Clinical Case Registry (CCR), and Home Dialysis Data Collection System, the Pharmacy Benefits Management database and the Consolidated Enrollment File. Most of the clinical data is Veterans Health Information Systems and Technology Architecture data which is transmitted to the Austin Information Technology Center (AITC) where it is retrieved by the ARC each month. The ARC also retrieves DSS cost data from the AITC as well. Some additional information is received from the Hines Pharmacy Benefits Management and the CCR databases. The data from these sources is combined to develop patient-specific care and cost data for each hospitalization or visit at the location or treatment level. Aggregate tables summarize this data for reporting and analysis purposes. The VERA databases are the basis for resource allocation in the Veterans Health Administration.

  14. E

    Cell-free DNA and bone marrow samples from myelodysplastic syndromes

    • ega-archive.org
    Updated Sep 15, 2023
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    (2023). Cell-free DNA and bone marrow samples from myelodysplastic syndromes [Dataset]. https://ega-archive.org/datasets/EGAD00001008567
    Explore at:
    Dataset updated
    Sep 15, 2023
    License

    https://ega-archive.org/dacs/EGAC00001002512https://ega-archive.org/dacs/EGAC00001002512

    Description

    We have assessed the molecular profile of a cohort of 70 patients with MDS by next-generation sequencing (NGS) using cfDNA and compared the results to paired bone marrow (BM) DNA.

  15. f

    Data from: Comparison of Intraocular Antibody Measurement, Quantitative...

    • tandf.figshare.com
    xlsx
    Updated Feb 15, 2024
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Li Wang; Zhujian Wang; Jinmin Ma; Qiongfang Li; Xueli Chen; Yuhong Chen; Xinghuai Sun (2024). Comparison of Intraocular Antibody Measurement, Quantitative Pathogen PCR, and Metagenomic Deep Sequencing of Aqueous Humor in Secondary Glaucoma Associated with Anterior Segment Uveitis [Dataset]. http://doi.org/10.6084/m9.figshare.12850937.v1
    Explore at:
    xlsxAvailable download formats
    Dataset updated
    Feb 15, 2024
    Dataset provided by
    Taylor & Francis
    Authors
    Li Wang; Zhujian Wang; Jinmin Ma; Qiongfang Li; Xueli Chen; Yuhong Chen; Xinghuai Sun
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Description

    To identify viral pathogens in patients with secondary glaucoma associated with anterior segment uveitis and compare metagenomic deep sequencing (MDS) with enzyme-linked immunosorbent assay (ELISA) combined with Witmer-Desmonts coefficient (WDC) evaluation and real-time quantitative polymerase chain reaction (qPCR) on investigating pathogens in aqueous humor. Aqueous humor from 31 patients, including 22 Posner-Schlossman Syndrome and 9 other anterior uveitis, was assessed pathogens by ELISA combined with WDC evaluation, virus deoxyribonucleic acid (DNA) detection by real-time qPCR and MDS. Viral pathogens (HCMV or VZV or RV) were detected in 19 out of 31 eyes (61.3%) by real-time qPCR or WDC evaluation. MDS revealed the presence of HCMV DNA sequences in three PSS patients. Virus is an important pathogen in secondary glaucoma associated with anterior segment uveitis. MDS is a potential etiologic diagnosis tool to seek intraocular viral pathogens for secondary glaucoma associated anterior segment uveitis.

  16. Z

    Data from: A blinded, controlled trial of objective measurement in...

    • data.niaid.nih.gov
    • zenodo.org
    Updated Jun 3, 2022
    + more versions
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Kotschet, Katya (2022). A blinded, controlled trial of objective measurement in Parkinson's disease [Dataset]. https://data.niaid.nih.gov/resources?id=zenodo_5009813
    Explore at:
    Dataset updated
    Jun 3, 2022
    Dataset provided by
    Fernando, Chathurini
    Horne, Malcolm
    Woodrow, Holly
    Kotschet, Katya
    License

    CC0 1.0 Universal Public Domain Dedicationhttps://creativecommons.org/publicdomain/zero/1.0/
    License information was derived automatically

    Description

    Medical conditions with effective therapies are usually managed with objective measurement and therapeutic targets. Parkinson's disease has effective therapies, but continuous objective measurement has only recently become available. This blinded, controlled study examined whether management of Parkinson's disease was improved when clinical assessment and therapeutic decisions were aided by objective measurement. The primary endpoint was improvement in the Movement Disorder Society-United Parkinson's Disease Rating Scale's (MDS-UPDRS) Total Score. In one arm, objective measurement assisted doctors to alter therapy over successive visits until objective measurement scores were in target. Patients in the other arm were conventionally assessed and therapies were changed until judged optimal. There were 75 subjects in the objective measurement arm and 79 in the arm with conventional assessment and treatment. There were statistically significant improvements in the moderate clinically meaningful range in the MDS-UPDRS Total, III, IV scales in the arm using objective measurement, but not in the conventionally treated arm. These findings show that global motor and non-motor disability is improved when the management of Parkinson's disease is assisted by objective measurement.

  17. f

    Table_1_Secondary myeloid neoplasms after CD19 CAR T therapy in patients...

    • figshare.com
    xlsx
    Updated Jun 16, 2023
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Aiqi Zhao; Mingzhe Zhao; Wenbin Qian; Aibin Liang; Ping Li; Hui Liu (2023). Table_1_Secondary myeloid neoplasms after CD19 CAR T therapy in patients with refractory/relapsed B-cell lymphoma: Case series and review of literature.xlsx [Dataset]. http://doi.org/10.3389/fimmu.2022.1063986.s001
    Explore at:
    xlsxAvailable download formats
    Dataset updated
    Jun 16, 2023
    Dataset provided by
    Frontiers
    Authors
    Aiqi Zhao; Mingzhe Zhao; Wenbin Qian; Aibin Liang; Ping Li; Hui Liu
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Description

    BackgroundSeveral chimeric antigen receptor T cells (CAR T) targeting CD19 have induced profound and prolonged remission for refractory/relapsed (R/R) B-cell lymphoma. The risk of secondary malignancies, especially myeloid neoplasms, is of particular concern in the CAR T community, which still remains unclear.MethodsFour patients with R/R B-cell lymphoma after CD19 CAR T therapy diagnosed with secondary myeloid neoplasms (SMN) from 2 hospitals in eastern China were presented, including 3 with myelodysplastic syndrome (MDS) and 1 with acute myeloid leukemia (AML). Using single-cell RNA sequencing (scRNA-seq), we compared the cellular components of bone marrow (BM) samples obtained from one of these MDS patients and a health donor. We also provided a review of recently published literature concerning SMN risk of CAR T therapy.ResultsRelevant demographic, clinical, laboratory, therapeutic and outcome data were collected and presented by chart review. In our case series, the male-female ratio was 3.0 and the median age at MDS onset was 61.25 years old (range, 50-78). Median number of previous systemic therapies was 4.5 (range, 4-5), including autologous hematopoietic stem cell transplantation (auto-HSCT) in one patient. BM assessments prior to CAR T therapy confirmed normal hematopoiesis without myeloid neoplasms. Moreover, for 3 patients with SMN in our series, cytogenetic analysis predicted a relatively adverse outcome. In our experience and in the literature, treatment choices for the patients with SMN included allogeneic hematopoietic stem cell transplantation (allo-HSCT), hypomethylating agent (HMA), period filgrastim, transfusions and other supportive care. Finally, treatment responses of lymphoma, together with SMN, directly correlated with the overall survival of this community. Of note, it appeared that pathogenesis of MDS wasn’t associated with the CAR T toxicities, since all 4 patients experienced a pretty mild CRS of grade 1-2. Additionally, scRNA-seq analysis described the transcriptional alteration of CD34+ cells, identified 13 T/NK clusters, and also indicated increased cytotoxic T cells in MDS BM.ConclusionOur study illustrated the onset and progression of SMN after CD19 CAR T therapy in patients with R/R B-cell lymphoma, which provides useful information of this uncommon later event.

  18. f

    Data from: S1 Dataset -

    • plos.figshare.com
    xlsx
    Updated Jul 18, 2024
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Navid Behzadi Koochani; Raúl Muñoz Romo; Ignacio Hernández Palencia; Sergio López Bernal; Carmen Martin Curto; José Cabezas Rodríguez; Almudena Castaño Reguillo (2024). S1 Dataset - [Dataset]. http://doi.org/10.1371/journal.pone.0305699.s002
    Explore at:
    xlsxAvailable download formats
    Dataset updated
    Jul 18, 2024
    Dataset provided by
    PLOS ONE
    Authors
    Navid Behzadi Koochani; Raúl Muñoz Romo; Ignacio Hernández Palencia; Sergio López Bernal; Carmen Martin Curto; José Cabezas Rodríguez; Almudena Castaño Reguillo
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Description

    IntroductionThere is a need to develop harmonized procedures and a Minimum Data Set (MDS) for cross-border Multi Casualty Incidents (MCI) in medical emergency scenarios to ensure appropriate management of such incidents, regardless of place, language and internal processes of the institutions involved. That information should be capable of real-time communication to the command-and-control chain. It is crucial that the models adopted are interoperable between countries so that the rights of patients to cross-border healthcare are fully respected.ObjectiveTo optimize management of cross-border Multi Casualty Incidents through a Minimum Data Set collected and communicated in real time to the chain of command and control for each incident. To determine the degree of agreement among experts.MethodWe used the modified Delphi method supplemented with the Utstein technique to reach consensus among experts. In the first phase, the minimum requirements of the project, the profile of the experts who were to participate, the basic requirements of each variable chosen and the way of collecting the data were defined by providing bibliography on the subject. In the second phase, the preliminary variables were grouped into 6 clusters, the objectives, the characteristics of the variables and the logistics of the work were approved. Several meetings were held to reach a consensus to choose the MDS variables using a Modified Delphi technique. Each expert had to score each variable from 1 to 10. Non-voting variables were eliminated, and the round of voting ended. In the third phase, the Utstein Style was applied to discuss each group of variables and choose the ones with the highest consensus. After several rounds of discussion, it was agreed to eliminate the variables with a score of less than 5 points. In phase four, the researchers submitted the variables to the external experts for final assessment and validation before their use in the simulations. Data were analysed with SPSS Statistics (IBM, version 2) software.ResultsSix data entities with 31 sub-entities were defined, generating 127 items representing the final MDS regarded as essential for incident management. The level of consensus for the choice of items was very high and was highest for the category ‘Incident’ with an overall kappa of 0.7401 (95% CI 0.1265–0.5812, p 0.000), a good level of consensus in the Landis and Koch model. The items with the greatest degree of consensus at ten were those relating to location, type of incident, date, time and identification of the incident. All items met the criteria set, such as digital collection and real-time transmission to the chain of command and control.ConclusionsThis study documents the development of a MDS through consensus with a high degree of agreement among a group of experts of different nationalities working in different fields. All items in the MDS were digitally collected and forwarded in real time to the chain of command and control. This tool has demonstrated its validity in four large cross-border simulations involving more than eight countries and their emergency services.

  19. f

    Methodological quality assessment (risk of bias) of included studies by...

    • figshare.com
    • plos.figshare.com
    xls
    Updated May 31, 2023
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Claudia Pileggi; Maddalena Di Sanzo; Valentina Mascaro; Maria Grazia Marafioti; Francesco Saverio Costanzo; Maria Pavia (2023). Methodological quality assessment (risk of bias) of included studies by Newcastle-Ottawa Scale. [Dataset]. http://doi.org/10.1371/journal.pone.0179016.t001
    Explore at:
    xlsAvailable download formats
    Dataset updated
    May 31, 2023
    Dataset provided by
    PLOS ONE
    Authors
    Claudia Pileggi; Maddalena Di Sanzo; Valentina Mascaro; Maria Grazia Marafioti; Francesco Saverio Costanzo; Maria Pavia
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Description

    For each domain, either a "star" or "no star" is assigned, with a "star" indicating that study design element was considered adequate and less likely to introduce bias. A maximum of two stars can be given for Comparability. A study could receive a maximum of ten stars.

  20. f

    Mediterranean diet and physical functioning trajectories in Eastern Europe:...

    • plos.figshare.com
    pdf
    Updated Jun 8, 2023
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Denes Stefler; Yaoyue Hu; Sofia Malyutina; Andrzej Pajak; Ruzena Kubinova; Anne Peasey; Hynek Pikhart; Fernando Rodriguez-Artalejo; Martin Bobak (2023). Mediterranean diet and physical functioning trajectories in Eastern Europe: Findings from the HAPIEE study [Dataset]. http://doi.org/10.1371/journal.pone.0200460
    Explore at:
    pdfAvailable download formats
    Dataset updated
    Jun 8, 2023
    Dataset provided by
    PLOS ONE
    Authors
    Denes Stefler; Yaoyue Hu; Sofia Malyutina; Andrzej Pajak; Ruzena Kubinova; Anne Peasey; Hynek Pikhart; Fernando Rodriguez-Artalejo; Martin Bobak
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Area covered
    Europe, Eastern Europe
    Description

    BackgroundUnhealthy diet may increase the risk of impaired physical functioning in older age. Although poor diet and limited physical functioning both seem to be particularly common in Eastern Europe, no previous study has assessed the relationship between these two factors in this region. The current analysis examined the association between overall diet quality and physical functioning in Eastern European populations.MethodsWe used data on 25,504 persons (aged 45–69 years at baseline) who participated in the Health Alcohol and Psychosocial factors in Eastern Europe (HAPIEE) study. Dietary assessment at baseline used food frequency questionnaire, and the overall diet quality was evaluated by the Mediterranean diet score (MDS). Physical functioning (PF) was measured by the physical functioning subscale (PF-10) of the 36-item Short-Form Health Survey at baseline and three subsequent occasions over a 10-year period. The cross-sectional and longitudinal relationships between the MDS and PF were examined simultaneously using growth curve models.ResultsMen and women with higher adherence to the Mediterranean diet had significantly better PF at baseline; after multivariable adjustment, the regression coefficient per 1-unit increase in the MDS was 0.39 (95% CI: 0.25, 0.52) in men and 0.50 (0.36, 0.64) in women. However, we found no statistically significant link between baseline MDS and the subsequent slope of PF decline in neither gender; the coefficients were -0.02 (-0.04, 0.00) in men and -0.01 (-0.03, 0.02) in women.DiscussionOur results do not support the hypothesis that the Mediterranean diet has a substantial impact on the trajectories of physical functioning, although the differences existing at baseline may be related to dietary habits in earlier life.

Share
FacebookFacebook
TwitterTwitter
Email
Click to copy link
Link copied
Close
Cite
Centers for Medicare & Medicaid Services (2025). Minimum Data Set Frequency [Dataset]. https://catalog.data.gov/dataset/minimum-data-set-frequency

Minimum Data Set Frequency

Explore at:
5 scholarly articles cite this dataset (View in Google Scholar)
Dataset updated
Feb 3, 2025
Dataset provided by
Centers for Medicare & Medicaid Services
Description

The Minimum Data Set (MDS) Frequency data summarizes health status indicators for active residents currently in nursing homes. The MDS is part of the Federally-mandated process for clinical assessment of all residents in Medicare and Medicaid certified nursing homes. This process provides a comprehensive assessment of each resident's functional capabilities and helps nursing home staff identify health problems. Care Area Assessments (CAAs) are part of this process, and provide the foundation upon which a resident's individual care plan is formulated. MDS assessments are completed for all residents in certified nursing homes, regardless of source of payment for the individual resident. MDS assessments are required for residents on admission to the nursing facility, periodically, and on discharge. All assessments are completed within specific guidelines and time frames. In most cases, participants in the assessment process are licensed health care professionals employed by the nursing home. MDS information is transmitted electronically by nursing homes to the national MDS database at CMS. When reviewing the MDS 3.0 Frequency files, some common software programs e.g., ‘Microsoft Excel’ might inaccurately strip leading zeros from designated code values (i.e., "01" becomes "1") or misinterpret code ranges as dates (i.e., O0600 ranges such as 02-04 are misread as 04-Feb). As each piece of software is unique, if you encounter an issue when reading the CSV file of Frequency data, please open the file in a plain text editor such as ‘Notepad’ or ‘TextPad’ to review the underlying data, before reaching out to CMS for assistance.

Search
Clear search
Close search
Google apps
Main menu